Presentation is loading. Please wait.

Presentation is loading. Please wait.

Table 1 Organisms for which rapid identification criteria are included. From: Rapid Identification of Bacteria and Yeast: Summary of a National Committee.

Published byMervin Malcolm Watkins Modified over 6 years ago

Similar presentations

Presentation on theme: "Table 1 Organisms for which rapid identification criteria are included. From: Rapid Identification of Bacteria and Yeast: Summary of a National Committee."— Presentation transcript:

1 Table 1 Organisms for which rapid identification criteria are included.
From: Rapid Identification of Bacteria and Yeast: Summary of a National Committee for Clinical Laboratory Standards Proposed Guideline Clin Infect Dis. 2001;33(2): doi: /321816 Clin Infect Dis | © 2001 by the Infectious Diseases Society of America

2 Figure 1 Scheme for rapid identification of Escherichia coli isolated from sites other than blood and feces. BAP, blood agar plate; MUG, methyl-umbelliferryl β-glucuronidase reagent; PYR, pyrrolidonyl aminopeptidase reagent. Permission to adapt portions of document M35-P (Abbreviated Identification of Bacteria and Yeast; Proposed Guideline) has been granted by the National Committee for Clinical Laboratory Standards (NCCLS). Copies of the current edition may be obtained from the NCCLS (940 West Valley Rd., Ste. 1400, Wayne, PA 19087). From: Rapid Identification of Bacteria and Yeast: Summary of a National Committee for Clinical Laboratory Standards Proposed Guideline Clin Infect Dis. 2001;33(2): doi: /321816 Clin Infect Dis | © 2001 by the Infectious Diseases Society of America

3 Table 2 Rapid (within 1 h) identification of aerobic gram-negative rods.
From: Rapid Identification of Bacteria and Yeast: Summary of a National Committee for Clinical Laboratory Standards Proposed Guideline Clin Infect Dis. 2001;33(2): doi: /321816 Clin Infect Dis | © 2001 by the Infectious Diseases Society of America

4 Table 3 Rapid (within 30 min-2 h) identification of Enterococcus species, streptococci, and Staphylococcus aureus. From: Rapid Identification of Bacteria and Yeast: Summary of a National Committee for Clinical Laboratory Standards Proposed Guideline Clin Infect Dis. 2001;33(2): doi: /321816 Clin Infect Dis | © 2001 by the Infectious Diseases Society of America

5 Table 4 Rapid (within 30 min) identification of anaerobic gram-negative bacteria.
From: Rapid Identification of Bacteria and Yeast: Summary of a National Committee for Clinical Laboratory Standards Proposed Guideline Clin Infect Dis. 2001;33(2): doi: /321816 Clin Infect Dis | © 2001 by the Infectious Diseases Society of America

6 Table 5 Rapid identification of anaerobic gram-positive bacteria.
From: Rapid Identification of Bacteria and Yeast: Summary of a National Committee for Clinical Laboratory Standards Proposed Guideline Clin Infect Dis. 2001;33(2): doi: /321816 Clin Infect Dis | © 2001 by the Infectious Diseases Society of America

Download ppt "Table 1 Organisms for which rapid identification criteria are included. From: Rapid Identification of Bacteria and Yeast: Summary of a National Committee."

Similar presentations

Table 4 Risk factors for acquisition of vancomycin-resistant enterococcal (VRE) colonization after transplantation for 120 liver transplant recipients.

Table 4 Risk factors for acquisition of vancomycin-resistant enterococcal (VRE) colonization after transplantation for 120 liver transplant recipients.
Table 5 Characteristics of 12 patients who had 1 test of stool samples that yielded positive results in the prospective clinical assessment for investigation.

Table 5 Characteristics of 12 patients who had 1 test of stool samples that yielded positive results in the prospective clinical assessment for investigation.
Table 3 Titers of antibody to hepatitis B surface antigen (anti-HBs) 2–4 weeks after the first vaccination From: Response to Hepatitis B Vaccine in HIV-1–Positive.

Table 3 Titers of antibody to hepatitis B surface antigen (anti-HBs) 2–4 weeks after the first vaccination From: Response to Hepatitis B Vaccine in HIV-1–Positive.
Table 6 The results of virus isolation tests before and after oseltamivir therapy. From: A Comparison of the Effectiveness of Oseltamivir for the Treatment.

Table 6 The results of virus isolation tests before and after oseltamivir therapy. From: A Comparison of the Effectiveness of Oseltamivir for the Treatment.
Figure 1. Shiga toxin–producing Escherichia coli (STEC) isolates by method of initial detection and STEC serotype, Connecticut, 2000–2009. From: Ten-Year.

Figure 1. Shiga toxin–producing Escherichia coli (STEC) isolates by method of initial detection and STEC serotype, Connecticut, 2000–2009. From: Ten-Year.
Table 1 Characteristics of the 968 Women in the Study Group

Table 1 Characteristics of the 968 Women in the Study Group
Table 3 Identification of Lactobacillus species isolated from blood cultures from Helsinki University Central Hospital, 1990–2000, and stored isolates.

Table 3 Identification of Lactobacillus species isolated from blood cultures from Helsinki University Central Hospital, 1990–2000, and stored isolates.
Table 1 Demographic and clinical characteristics of 758 admitted patients for whom cultures of nares were performed to assess methicillin-resistant Staphylococcus.

Table 1 Demographic and clinical characteristics of 758 admitted patients for whom cultures of nares were performed to assess methicillin-resistant Staphylococcus.
Table 1 Specificity of IgM immunoblot assay of sera collected during the winter and early spring months from volunteers without clinical evidence of Lyme.

Table 1 Specificity of IgM immunoblot assay of sera collected during the winter and early spring months from volunteers without clinical evidence of Lyme.
Figure 1. Algorithm for classifying patients with hospital-acquired pneumonia according to the Consensus Statement of the American Thoracic Society. Adapted.

Figure 1. Algorithm for classifying patients with hospital-acquired pneumonia according to the Consensus Statement of the American Thoracic Society. Adapted.
From: Unmasking Masks in Makkah: Preventing Influenza at Hajj

From: Unmasking Masks in Makkah: Preventing Influenza at Hajj
From: Rotarix: A Rotavirus Vaccine for the World

From: Rotarix: A Rotavirus Vaccine for the World
Laboratory diagnosis and biosafety issues of biological warfare agents

Laboratory diagnosis and biosafety issues of biological warfare agents
Table 1 Criteria for proven invasive fungal disease except for endemic mycoses. From: Revised Definitions of Invasive Fungal Disease from the European.

Table 1 Criteria for proven invasive fungal disease except for endemic mycoses. From: Revised Definitions of Invasive Fungal Disease from the European.
From: Postinfectious Irritable Bowel Syndrome

From: Postinfectious Irritable Bowel Syndrome
Figure 1 Adverse events after typhoid fever vaccination reported to the Vaccine Adverse Events Reporting System, by vaccination date and vaccine type,

Figure 1 Adverse events after typhoid fever vaccination reported to the Vaccine Adverse Events Reporting System, by vaccination date and vaccine type,
Table 5 Sample format for results of Streptococcus pneumoniae isolate testing in a laboratory that routinely performs only oxacillin disk tests for penicillin.

Table 5 Sample format for results of Streptococcus pneumoniae isolate testing in a laboratory that routinely performs only oxacillin disk tests for penicillin.
Figure 1 Annual per-capita consumption of all fermented milks and yogurt only in selected countries in Europe and North America [3, 4]. From: Probiotic.

Figure 1 Annual per-capita consumption of all fermented milks and yogurt only in selected countries in Europe and North America [3, 4]. From: Probiotic.
Figure 1 Flow chart distinguishing groups according to receipt of azithromycin treatment and method of data collection. Circles containing the abbreviation.

Figure 1 Flow chart distinguishing groups according to receipt of azithromycin treatment and method of data collection. Circles containing the abbreviation.
Natural antibiotic susceptibility of Listeria species: L. grayi, L

Natural antibiotic susceptibility of Listeria species: L. grayi, L

Similar presentations

Ads by Google